Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Penyata Pendapatan (TTM)

Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US00653A1079

Penyata Pendapatan (TTM)

Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 3 4 4 6 6 6 9 12 18 27 71 71 71 60 18 141 175 178 180 65
Perubahan (%) 24.31 -8.26 71.41 0.16 -1.36 51.08 26.30 49.47 54.80 162.17 -0.57 0.44 -15.19 -69.55 670.56 23.74 1.71 0.90 -63.77
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 86 92 95 103 107 111 123 129 30 128 117 112 221 127 136 147 143 149 144 129
Perubahan (%) 6.30 3.54 8.87 4.01 3.47 11.02 4.76 -77.16 332.90 -8.77 -4.10 97.79 -42.76 7.64 7.70 -2.38 4.17 -3.67 -10.42
% daripada Hasil 2,705.56 2,313.49 2,611.13 1,658.39 1,722.20 1,806.64 1,327.62 1,101.24 168.24 470.48 163.71 157.91 310.96 209.87 741.74 103.67 81.79 83.77 79.97 197.73
Keuntungan Operasi Kasar -83 -88 -91 -97 -101 -105 -114 -117 -12 -101 -45 -41 -150 -66 -118 -5 32 29 36 -64
Perubahan (%) 5.60 4.07 6.38 4.26 3.77 8.68 3.01 -89.81 740.39 -54.91 -9.63 265.90 -55.83 77.89 -95.59 -713.91 -9.32 24.49 -276.78
% daripada Hasil -2,605.56 -2,213.49 -2,511.13 -1,558.39 -1,622.20 -1,706.64 -1,227.62 -1,001.24 -68.24 -370.48 -63.71 -57.91 -210.96 -109.87 -641.74 -3.67 18.21 16.23 20.03 -97.73
SG&A 43 46 50 54 56 57 60 61 63 63 59 61 68 64 70 72 70 81 83 84
Perubahan (%) 5.80 9.95 6.44 4.05 2.76 5.21 1.68 2.68 0.70 -7.07 4.13 10.62 -4.99 7.93 3.02 -2.86 16.78 2.32 1.28
% daripada Hasil 1,359.48 1,157.02 1,386.70 861.10 894.56 931.94 649.00 522.48 358.93 233.49 82.76 86.68 95.46 106.94 378.99 50.67 39.78 45.67 46.31 129.47
R&D 105 -105
Perubahan (%)
% daripada Hasil 596.88 -147.27
OpEx 129 137 145 157 163 168 184 191 197 191 175 173 184 191 206 218 213 230 227 213
Perubahan (%) 6.13 5.68 8.03 4.03 3.23 9.05 3.75 3.47 -3.05 -8.21 -1.34 6.42 3.67 7.73 6.12 -2.54 8.29 -1.55 -6.13
% daripada Hasil 4,065.04 3,470.52 3,997.82 2,519.49 2,616.76 2,738.58 1,976.62 1,623.72 1,124.05 703.97 246.48 244.59 259.16 316.80 1,120.73 154.34 121.57 129.44 126.29 327.19
Pendapatan operasi -126 -133 -142 -151 -157 -162 -174 -179 -180 -164 -104 -102 -113 -131 -187 -77 -38 -52 -47 -148
Perubahan (%) 5.67 6.09 6.40 4.19 3.41 7.45 2.55 0.45 -8.70 -36.42 -1.86 10.56 15.53 43.38 -58.98 -50.89 38.83 -9.90 213.16
% daripada Hasil -3,965.04 -3,370.52 -3,897.82 -2,419.49 -2,516.76 -2,638.58 -1,876.62 -1,523.72 -1,024.05 -603.97 -146.48 -144.59 -159.16 -216.80 -1,020.73 -54.34 -21.57 -29.44 -26.29 -227.19
Perbelanjaan Faedah -1 -1 -2 -3 -5 -6
Perubahan (%) 210.84 104.77 56.18 8.34
% daripada Hasil -12.75 -0.37 -0.93 -1.88 -2.91 -8.70
Pendapatan bersih -123 -130 -140 -149 -156 -158 -171 -176 -175 -165 -114 -91 -95 -114 -163 -72 -45 -71 -70 -170
Perubahan (%) 5.90 7.38 6.58 4.68 1.44 7.91 3.20 -0.56 -5.49 -31.01 -20.26 4.59 19.61 43.50 -55.63 -38.60 59.08 -1.30 142.87
% daripada Hasil -3,858.13 -3,286.81 -3,847.09 -2,391.97 -2,499.92 -2,570.99 -1,836.30 -1,500.42 -998.26 -609.46 -160.39 -128.63 -133.94 -188.90 -890.13 -51.25 -25.43 -39.78 -38.91 -260.82

Source: Capital IQ

Other Listings
DE:473A €0.03
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista